Jing Qu1, Lanyan Zhu1,2, Zijing Zhou1,2, Ping Chen2, Shuyan Liu1,3, Morgan L Locy1, Victor J Thannickal1, Yong Zhou1. 1. 1 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama. 2. 2 Department of Respiratory Medicine, The Second Xiangya Hospital, Central-South University, Changsha, Hunan, China; and. 3. 3 Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, Jilin, China.
Abstract
RATIONALE: DSP (desmoplakin), the most abundant component of desmosomes, which maintain the mechanical integrity of epithelium, is a genome-wide association study-identified genetic risk locus in human idiopathic pulmonary fibrosis (IPF). Subjects with IPF express a significantly higher level of DSP than control subjects. OBJECTIVES: Determine potential mechanisms by which DSP is regulated in lung fibrosis. METHODS: Matrigel-coated soft and stiff polyacrylamide gels were made to simulate the stiffness of normal and fibrotic lungs. Quantitative chromatin immunoprecipitation and electrophoretic mobility shift assay were used to evaluate transcription factor binding to the DSP promoter. Targeted DNA methylation was achieved by CRISPR (clustered regularly interspaced short palindromic repeats)/dCas9 (deactivated CRISPR-associated protein-9 nuclease)-mediated Dnmt3A (DNA methyltransferase 3A) expression under the guidance of sequence-specific single guide RNAs. MEASUREMENTS AND MAIN RESULTS: Stiff matrix promotes DSP gene expression in both human and rodent lung epithelial cells as compared with soft matrix. A conserved region in the proximal DSP promoter is hypermethylated under soft matrix conditions and becomes hypomethylated/demethylated under stiff matrix conditions. Demethylation of this conserved DSP promoter region is associated with transactivation of transcription factor EGR1 (early growth response protein 1), resulting in EGR1-dependent DSP overexpression. Targeted DNA methylation by CRISPR/dCas9/Dnmt3A-mediated epigenome editing blocks EGR1 binding to the DSP promoter and inhibits stiff matrix-induced DSP overexpression. CONCLUSIONS: DSP is a matrix stiffness-regulated mechanosensitive gene. CRISPR/dCas9-Dnmt3A-mediated epigenome editing reverses DSP overexpression by reestablishment of the epigenetic control of DSP under the mechanically homeostatic environment. It provides a useful tool for investigations of the functional role of DSP in the pathogenesis of lung fibrosis.
RATIONALE: DSP (desmoplakin), the most abundant component of desmosomes, which maintain the mechanical integrity of epithelium, is a genome-wide association study-identified genetic risk locus in human idiopathic pulmonary fibrosis (IPF). Subjects with IPF express a significantly higher level of DSP than control subjects. OBJECTIVES: Determine potential mechanisms by which DSP is regulated in lung fibrosis. METHODS: Matrigel-coated soft and stiff polyacrylamide gels were made to simulate the stiffness of normal and fibrotic lungs. Quantitative chromatin immunoprecipitation and electrophoretic mobility shift assay were used to evaluate transcription factor binding to the DSP promoter. Targeted DNA methylation was achieved by CRISPR (clustered regularly interspaced short palindromic repeats)/dCas9 (deactivated CRISPR-associated protein-9 nuclease)-mediated Dnmt3A (DNA methyltransferase 3A) expression under the guidance of sequence-specific single guide RNAs. MEASUREMENTS AND MAIN RESULTS: Stiff matrix promotes DSP gene expression in both human and rodent lung epithelial cells as compared with soft matrix. A conserved region in the proximal DSP promoter is hypermethylated under soft matrix conditions and becomes hypomethylated/demethylated under stiff matrix conditions. Demethylation of this conserved DSP promoter region is associated with transactivation of transcription factor EGR1 (early growth response protein 1), resulting in EGR1-dependent DSP overexpression. Targeted DNA methylation by CRISPR/dCas9/Dnmt3A-mediated epigenome editing blocks EGR1 binding to the DSP promoter and inhibits stiff matrix-induced DSP overexpression. CONCLUSIONS: DSP is a matrix stiffness-regulated mechanosensitive gene. CRISPR/dCas9-Dnmt3A-mediated epigenome editing reverses DSP overexpression by reestablishment of the epigenetic control of DSP under the mechanically homeostatic environment. It provides a useful tool for investigations of the functional role of DSP in the pathogenesis of lung fibrosis.
Authors: Denes Hnisz; Brian J Abraham; Tong Ihn Lee; Ashley Lau; Violaine Saint-André; Alla A Sigova; Heather A Hoke; Richard A Young Journal: Cell Date: 2013-10-10 Impact factor: 41.582
Authors: Xiangwei Huang; Naiheng Yang; Vincent F Fiore; Thomas H Barker; Yi Sun; Stephan W Morris; Qiang Ding; Victor J Thannickal; Yong Zhou Journal: Am J Respir Cell Mol Biol Date: 2012-03-29 Impact factor: 6.914
Authors: Xue Gao; Yong Tao; Veronica Lamas; Mingqian Huang; Wei-Hsi Yeh; Bifeng Pan; Yu-Juan Hu; Johnny H Hu; David B Thompson; Yilai Shu; Yamin Li; Hongyang Wang; Shiming Yang; Qiaobing Xu; Daniel B Polley; M Charles Liberman; Wei-Jia Kong; Jeffrey R Holt; Zheng-Yi Chen; David R Liu Journal: Nature Date: 2017-12-20 Impact factor: 49.962
Authors: Richard J Allen; Joanne Porte; Rebecca Braybrooke; Carlos Flores; Tasha E Fingerlin; Justin M Oldham; Beatriz Guillen-Guio; Shwu-Fan Ma; Tsukasa Okamoto; Alison E John; Ma'en Obeidat; Ivana V Yang; Amanda Henry; Richard B Hubbard; Vidya Navaratnam; Gauri Saini; Norma Thompson; Helen L Booth; Simon P Hart; Mike R Hill; Nik Hirani; Toby M Maher; Robin J McAnulty; Ann B Millar; Philip L Molyneaux; Helen Parfrey; Doris M Rassl; Moira K B Whyte; William A Fahy; Richard P Marshall; Eunice Oballa; Yohan Bossé; David C Nickle; Don D Sin; Wim Timens; Nick Shrine; Ian Sayers; Ian P Hall; Imre Noth; David A Schwartz; Martin D Tobin; Louise V Wain; R Gisli Jenkins Journal: Lancet Respir Med Date: 2017-10-20 Impact factor: 102.642
Authors: Tasha E Fingerlin; Elissa Murphy; Weiming Zhang; Anna L Peljto; Kevin K Brown; Mark P Steele; James E Loyd; Gregory P Cosgrove; David Lynch; Steve Groshong; Harold R Collard; Paul J Wolters; Williamson Z Bradford; Karl Kossen; Scott D Seiwert; Roland M du Bois; Christine Kim Garcia; Megan S Devine; Gunnar Gudmundsson; Helgi J Isaksson; Naftali Kaminski; Yingze Zhang; Kevin F Gibson; Lisa H Lancaster; Joy D Cogan; Wendi R Mason; Toby M Maher; Philip L Molyneaux; Athol U Wells; Miriam F Moffatt; Moises Selman; Annie Pardo; Dong Soon Kim; James D Crapo; Barry J Make; Elizabeth A Regan; Dinesha S Walek; Jerry J Daniel; Yoichiro Kamatani; Diana Zelenika; Keith Smith; David McKean; Brent S Pedersen; Janet Talbert; Raven N Kidd; Cheryl R Markin; Kenneth B Beckman; Mark Lathrop; Marvin I Schwarz; David A Schwartz Journal: Nat Genet Date: 2013-04-14 Impact factor: 38.330
Authors: Yuan Hao; Samuel Bates; Hongmei Mou; Jeong H Yun; Betty Pham; Jiangyuan Liu; Weiliang Qiu; Feng Guo; Jarrett D Morrow; Craig P Hersh; Christopher J Benway; Lu Gong; Yihan Zhang; Ivan O Rosas; Michael H Cho; Jin-Ah Park; Peter J Castaldi; Fei Du; Xiaobo Zhou Journal: Am J Respir Crit Care Med Date: 2020-11-01 Impact factor: 21.405
Authors: Qi Tan; Patrick A Link; Jeffrey A Meridew; Tho X Pham; Nunzia Caporarello; Giovanni Ligresti; Daniel J Tschumperlin Journal: Am J Respir Cell Mol Biol Date: 2021-04 Impact factor: 6.914
Authors: Peter McErlean; Christopher G Bell; Richard J Hewitt; Zabreen Busharat; Patricia P Ogger; Poonam Ghai; Gesa J Albers; Emily Calamita; Shaun Kingston; Philip L Molyneaux; Stephan Beck; Clare M Lloyd; Toby M Maher; Adam J Byrne Journal: Am J Respir Crit Care Med Date: 2021-10-15 Impact factor: 21.405
Authors: Fabienne Gally; Sarah K Sasse; Jonathan S Kurche; Margaret A Gruca; Jonathan H Cardwell; Tsukasa Okamoto; Hong W Chu; Xiaomeng Hou; Olivier B Poirion; Justin Buchanan; Sebastian Preissl; Bing Ren; Sean P Colgan; Robin D Dowell; Ivana V Yang; David A Schwartz; Anthony N Gerber Journal: JCI Insight Date: 2021-01-25